These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 20156948

  • 1. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
    Foster W, Carruthers D, Lip GY, Blann AD.
    J Rheumatol; 2010 Apr; 37(4):711-6. PubMed ID: 20156948
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis.
    Galarraga B, Khan F, Kumar P, Pullar T, Belch JJ.
    Rheumatology (Oxford); 2008 Dec; 47(12):1780-4. PubMed ID: 18854346
    [Abstract] [Full Text] [Related]

  • 4. Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis.
    Cardillo C, Schinzari F, Mores N, Mettimano M, Melina D, Zoli A, Ferraccioli G.
    Clin Pharmacol Ther; 2006 Sep; 80(3):275-81. PubMed ID: 16952494
    [Abstract] [Full Text] [Related]

  • 5. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
    Syngle A, Vohra K, Garg N, Kaur L, Chand P.
    Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
    [Abstract] [Full Text] [Related]

  • 6. An observational study of endothelial function in early arthritis.
    Foster W, Lip GY, Raza K, Carruthers D, Blann AD.
    Eur J Clin Invest; 2012 May; 42(5):510-6. PubMed ID: 21985471
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G.
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A.
    Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
    [Abstract] [Full Text] [Related]

  • 11. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P.
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [Abstract] [Full Text] [Related]

  • 12. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B, Chong AY, Nuttall S, Lip GY.
    Thromb Res; 2008 Mar; 122(1):85-90. PubMed ID: 17996280
    [Abstract] [Full Text] [Related]

  • 13. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D, Enseleit F, Ruschitzka F.
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BA, Boers M, Voskuyl AE, Diamant M, Wolbink GJ, Nieuwland R, Nurmohamed MT.
    Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
    [Abstract] [Full Text] [Related]

  • 16. Effects of selective and non-selective cyclo-oxygenase inhibition on endothelial function in patients with rheumatoid arthritis.
    Wong M, Jiang BY, McNeill K, Farish S, Kirkham B, Chowienczyk P.
    Scand J Rheumatol; 2007 Jul; 36(4):265-9. PubMed ID: 17763203
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis.
    Galarraga B, Khan F, Kumar P, Pullar T, Belch JJ.
    Rheumatology (Oxford); 2009 Nov; 48(11):1418-23. PubMed ID: 19734293
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.